---
schema_version: "secwatch.filing_event.v1"
accession: "0001575872-22-000277"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2022-04-15T23:59:59+00:00"
generated_at: "2026-06-26T07:12:36.866935+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Denali Capital Acquisition Corp. completes $82.5M IPO and $5.1M private placement

## Summary
- IPO of 8,250,000 units at $10.00/unit raised $82.5M gross; private placement of 510,000 units to sponsor raised $5.1M.
- Total $84.15M deposited into trust account for benefit of public shareholders; redemption value set at $10.20/share.
- Company has 12 months (extendable to 18) to complete a business combination or will liquidate.
- Each unit consists of one Class A share and one warrant exercisable at $11.50 per share.

## SEC filing metadata
- accession: 0001575872-22-000277
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2022-04-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000157587222000277/0001575872-22-000277-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000157587222000277/deca-20220411.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001575872-22-000277
- JSON: https://secwatch.observer/filing/0001575872-22-000277.json
- Plain text: https://secwatch.observer/filing/0001575872-22-000277.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
